Verona Pharma Plc News - VRP

Verona Pharma Shares Rise On Positive RPL554 Treatment Trial Data

News) - Verona Pharma PLC said Friday top-line data from a trial of its RPL554 treatment showed a "favourable" pharmac ...

Verona Pharma plc Verona Pharma Reports Positive Top-Line Data From Phase 2a Trial With Rpl554 In Cystic Fibrosis Patients

RPL554 demonstrates a favorable pharmacokinetic and pharmacodynamic profile in cystic fibrosis patients LONDON, March 02, 2018 (GLOBE NEWSWIRE...

Verona Pharma Reports Positive Top-Line Data from Phase 2a Trial with RPL554 in Cystic Fibrosis Patients

LONDON, March 02, 2018 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM:VRP) (Nasdaq:VRNA) (“Verona Pharma”), a...

Verona Pharma plc ("Verona Pharma" or the "Company") Reports Operational Update and Financial Results for Full Year Ended Dec...

LONDON, Feb. 27, 2018 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM:VRP) (Nasdaq:VRNA) (Verona Pharma), a...

Verona Pharma plc Verona Pharma Plc ("Verona Pharma" Or The "Company") Reports Operational Update And Financial Results For F...

LONDON, Feb. 27, 2018 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM:VRP) (Nasdaq:VRNA) (Verona Pharma), a clinical-stage biopharmaceutical company...

Verona Pharma plc Verona Pharma To Announce Operational Update And Financial Results For Full Year Ended December 31, 2017

LONDON, Feb. 22, 2018 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM:VRP) (Nasdaq:VRNA) ("Verona Pharma"), a clinical-stage...

Verona Pharma plc Verona Pharma Plc Operational Update And Financial Results For The Third Quarter Ended September 30, 2017

Emerging clinical data confirms the potential for RPL554 to be an important, novel treatment for patients with COPD LONDON, Nov. 07, 2017 (GLOBE...

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Verona Pharma Plc (VRP)

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

VRP News

Verona Pharma Shares Rise On Positive RPL554 Treatment Trial Data

Verona Pharma plc Verona Pharma Reports Positive Top-Line Data From Phase 2a Trial With Rpl554 In Cystic Fibrosis Patients

Verona Pharma Reports Positive Top-Line Data from Phase 2a Trial with RPL554 in Cystic Fibrosis Patients

Verona Pharma plc ("Verona Pharma" or the "Company") Reports Operational Update and Financial Results for Full Year Ended Dec...

Verona Pharma plc Verona Pharma Plc ("Verona Pharma" Or The "Company") Reports Operational Update And Financial Results For F...

Verona Pharma plc Verona Pharma To Announce Operational Update And Financial Results For Full Year Ended December 31, 2017

Verona Pharma to Announce Operational Update and Financial Results for Full Year ended December 31, 2017

Verona Pharma plc Verona Pharma Provides Clinical Development Update

Verona Pharma Provides Clinical Development Update

Verona Pharma plc Verona Pharma Plc : Block Listing Interim Review

DIRECTOR DEALINGS: Verona Pharma Chairman Spends GBP10,685 On Shares

Verona Pharma plc Verona Pharma Plc : Pdmr Dealing

PDMR Dealing

Verona Pharma Enrolls Over 200 Patients For COPD Study, Loss Widens

Verona Pharma plc Verona Pharma Plc Operational Update And Financial Results For The Third Quarter Ended September 30, 2017

VRP Discussion

Your Recent History

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Verona Pharma Plc (VRP) News

Verona Pharma Plc (VRP)

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

VRP News

Verona Pharma Shares Rise On Positive RPL554 Treatment Trial Data

Verona Pharma plc Verona Pharma Reports Positive Top-Line Data From Phase 2a Trial With Rpl554 In Cystic Fibrosis Patients

Verona Pharma Reports Positive Top-Line Data from Phase 2a Trial with RPL554 in Cystic Fibrosis Patients

Verona Pharma plc ("Verona Pharma" or the "Company") Reports Operational Update and Financial Results for Full Year Ended Dec...

Verona Pharma plc Verona Pharma Plc ("Verona Pharma" Or The "Company") Reports Operational Update And Financial Results For F...

Verona Pharma plc Verona Pharma To Announce Operational Update And Financial Results For Full Year Ended December 31, 2017

Verona Pharma to Announce Operational Update and Financial Results for Full Year ended December 31, 2017

Verona Pharma plc Verona Pharma Provides Clinical Development Update

Verona Pharma Provides Clinical Development Update

Verona Pharma plc Verona Pharma Plc : Block Listing Interim Review

DIRECTOR DEALINGS: Verona Pharma Chairman Spends GBP10,685 On Shares

Verona Pharma plc Verona Pharma Plc : Pdmr Dealing

PDMR Dealing

Verona Pharma Enrolls Over 200 Patients For COPD Study, Loss Widens

Verona Pharma plc Verona Pharma Plc Operational Update And Financial Results For The Third Quarter Ended September 30, 2017

VRP Discussion

Your Recent History